US Biomedical Advanced Research and Development Authority (BARDA)

BARDA Funds Gritstone Bio's Phase 2b Study for Covid-19 Vaccine Candidate

US biotechnology company Gritstone Bio has received a contract from the US Biomedical Advanced Research and Development Authority (BARDA) to conduct a Phase 2b comparative study evaluating the company’s self-amplifying mRNA (samRNA) vaccine candidate against Covid-19.

Curia Begins Work on New Mexico Expansion

US CDMO Curia has begun construction on an expansion of its campus in Albuquerque, New Mexico. The facility designed by Burns & McDonnell will be built by BE&K Building Group.

Croda Wins US Backing for Lipid Systems Expansion

UK specialty chemical company Croda International will receive up to $75 million from the US government to expand its US capacity to produce ingredients for lipid systems used in novel therapeutic drugs, such as mRNA vaccines.

Bavarian Nordic Wins Janssen Ebola Subcontract